This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health. Active years: 1994-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 4 
2 out of 3,693 
1 out of 1,217 
Years Active: 1994-2018
Title: Thomas F. Spande: Innovator in Nicotinic Acetylcholine Receptor Agonists
Introduction
Thomas F. Spande is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmacology, particularly in the development of nicotinic acetylcholine receptor agonists. With a total of 4 patents, his work has the potential to impact various neurological disorders.
Latest Patents
Among his latest patents, Spande has developed novel nicotinic acetylcholine receptor agonists, including phantasmidine and its derivatives. These inventions are aimed at treating disorders that respond to nicotinic acetylcholine receptor agonists, such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction. The methods disclosed in his patents provide innovative approaches to managing these complex conditions.
Career Highlights
Throughout his career, Thomas F. Spande has worked with esteemed institutions such as Indiana State University and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include John W. Daly and Hugo M. Garraffo. Their collaborative efforts have further advanced the research and development of therapeutic solutions in the realm of nicotinic acetylcholine receptor agonists.
Conclusion
Thomas F. Spande's innovative work in the field of nicotinic acetylcholine receptor agonists showcases his dedication to addressing significant health challenges. His contributions have the potential to improve the lives of many individuals suffering from neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile